Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: Opill OTC Self-Selection and Use
NCT04112095Phase 3Completed
- Sponsor
- HRA Pharma
- Start
- Sep 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of norgestrel in contraception, sponsored by HRA Pharma. Started Sep 2019; status: completed.
02
Drugs
norgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04112095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112095.